Advertisement

Intestinal Damage by Anti-inflammatory Agents

  • A. Macpherson
  • I. Bjarnason

Abstract

Non steroidal anti-inflammatory drugs (NSAIDs) are one of the most successful classes of therapeutic agents ever marketed. Hence their adverse effects on the gastrointestinal (GI) tract have become the commonest and most important cause of medically induced iatrogenic GI disease. Unfortunately, the medical community has been lulled into a misunderstanding of the GI site that most commonly suffers complications in patients on NSAIDs. To a large extent this is the consequence of the ‘intestinal myopia’ which results from the widespread availability of upper GI endoscopes, which rarely progress further than the second part of the duodenum. The ease with which gastroduodenal ulceration can be visualised is emphasised by the dramatic consequences of haemorrhage from a bleeding ulcer. In itself this is certainly a most significant clinical problem. It has been estimated that for every 500–800 prescriptions of NSAIDs, one patient experiences catastrophic GI complications in the shape of haemorrhage or perforation from a peptic ulcer (totalling 30,000–40,000 patients annually in the United Kingdom, and this results in a 10% mortality risk [3, 6, 33, 34, 38, 71]. However, these factors have concealed the fact that the small intestine is the commonest site of NSAID toxicity, resulting in considerable morbidity (and mortality) in chronic users of the drugs.

Keywords

Intestinal Permeability Mefenamic Acid Intestinal Damage Nsaid Treatment Gastroduodenal Mucosa 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Allison, MC, Howatson, AG, Torrance, CJ, Lee, FD, Russell, RI (1992) Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. N Engl J Med 327: 749–754PubMedCrossRefGoogle Scholar
  2. 2.
    Alpan, G, Eyal, F, Vinograd, I, Udassin, R, Amir, G, Mogle, P, Glick, B (1985) Localized intestinal perforation after enteral administration of indomethacin in premature infants. J Pediatr 106: 277–281PubMedCrossRefGoogle Scholar
  3. 3.
    Armstrong, CP, Blower, AL (1987) Nonsteroidal anti-inflammatory drugs and life threatening complications of peptic ulcer disease. Gut 28: 527–532PubMedCrossRefGoogle Scholar
  4. 4.
    Bahrt, KM, Korman, LY, Nashel, DJ (1984) Significance of a positive test for occult blood in stools of patients taking anti-inflammatory drugs. Arch Intern Med 144: 2165–2166PubMedCrossRefGoogle Scholar
  5. 5.
    Bartle, WR, Gupta, AK, Lazor, J (1986) Nonsteroidal anti-inflammatory drugs and gastrointestinal bleeding: a case-control study. Arch Intern Med 146: 2365–2367PubMedCrossRefGoogle Scholar
  6. 6.
    Beardon, PHG, Brown, SV, McDevitt, DG (1989) Gastrointestinal events in patients prescribed NSAIDs: a controlled study using record linkage in Tayside. Q J Med 71: 497–505PubMedGoogle Scholar
  7. 7.
    Berry, H, Seinson, D, Jones, H, Hamilton, EBD (1978) Indomethacin and naproxen suppositories in the treatment of rheumatoid arthritis. Ann Rheum Dis 37: 370–372PubMedCrossRefGoogle Scholar
  8. 8.
    Bjarnason, I, Williams, P, So, A, Zanelli, G, Levi, AJ, Gumpel, MJ, Peters, TJ, Ansell, B (1984) Intestinal permeability and inflammation in rheumatoid arthritis; effects of nonsteroidal anti-inflammatory drugs. Lancet II: 1171–1174CrossRefGoogle Scholar
  9. 9.
    Bjarnason, I, Zanelli, G, Smith, T, Prouse, P, De Lacey, G, Gumpel, MJ, Levi, A J (1987) Nonsteroidal anti-inflammatory drug induced inflammation in humans. Gastroenterology 93: 480–489PubMedGoogle Scholar
  10. 10.
    Bjarnason, I, Zanelli, G, Prouse, P, Smethurst, P, Smith, T, Levi, S, Gumpel, MJ, Levi, AJ (1987) Blood and protein loss via small intestinal inflammation induced by nonsteroidal anti-inflammatory drugs. Lancet II: 711–714CrossRefGoogle Scholar
  11. 11.
    Bjarnason, I, Price, AB, Zanelli, G, Smethurst, P, Burke, M, Gumpel, MJ, Levi, AJ (1988) Clinico-pathological features of NSAID induced small intestinal strictures. Gastroenterology 94: 1070–1074PubMedGoogle Scholar
  12. 12.
    Bjarnason, I, Smethurst, P, Fenn, GC, Lee, CF, Menzies, IS, Levi, AJ (1989) Misoprostol reduces indomethacin induced changes in human small intestinal permeability. Dig Dis Sci 34: 407–411PubMedCrossRefGoogle Scholar
  13. 13.
    Bjarnason, I, Hopkinson, N, Zanelli, G, Prouse, P, Gumpel, MJ, Levi, AJ (1990) The treatment of nonsteroidal anti-inflammatory drug induced enteropathy. Gut 31: 777–780PubMedCrossRefGoogle Scholar
  14. 14.
    Bjarnason, I, Hayllar, J, Smethurst, P, Price, AB, Menzies, IS, Gumpel, M J (1992) Metronidazole reduces inflammation and blood loss in NSAID enteropathy. Gut 33: 1204–1208PubMedCrossRefGoogle Scholar
  15. 15.
    Bravo, AC, Lowman, RM (1968) Benign ulcer of sigmoid colon. Radiology 90: 113–115PubMedGoogle Scholar
  16. 16.
    Campbell, K, Steele, RJC (1991) Non-steroidal anti-inflammatory drugs and complicated diverticular disease: a case-control study. Br J Surg 78: 190–191PubMedCrossRefGoogle Scholar
  17. 17.
    Cartwright, GE, Lee, GR (1972) The anaemia of chronic disorder. Br J Haematol 21: 147–152CrossRefGoogle Scholar
  18. 18.
    Collins, AJ, A du Toit, J (1987) Upper gastrointestinal findings and faecal occult blood in patients with rheumatic disease taking non-steroidal anti-inflammatory drugs. Br J Rheumatol 26: 295–298PubMedCrossRefGoogle Scholar
  19. 19.
    Corder, A (1987) Steroids, nonsteroidal anti-inflammatory drugs and serious complications of diverticular disease. Br J Med 295:1238CrossRefGoogle Scholar
  20. 20.
    Coutrot, S, Roland, D, Barbier, J, Marcq, PVD, Alcalay, M, Matuchansky, C (1978) Acute perforation of colonic diverticula associated with short term indo-methacin. Lancet II: 1055–1056CrossRefGoogle Scholar
  21. 21.
    Croft, DN, Wood, PWH (1967) Gastric mucosal and susceptability to occult gastrointestinal bleeding caused by aspirin. Br Med J I: 137–141CrossRefGoogle Scholar
  22. 22.
    Day, TK (1983) Intestinal perforation associated with slow release indomethacin capsules. Br Med J 287: 1671–1672CrossRefGoogle Scholar
  23. 23.
    Debenham, GP (1966) Ulcer of the caecum during oxyphenylbutazone (Tanderil) therapy. Can Med Assoc J 94: 1182–1184PubMedGoogle Scholar
  24. 24.
    Doman, DB, Goldberg, HJ (1986) A case of meclofenamate sodium-induced colitis. Am J Gastroenterol 81: 1220–1221PubMedGoogle Scholar
  25. 25.
    Edwards, AL, Heagerty, AM, Bing, RF (1983) Enteritis and colitis associated with mefenamic acid. Br Med J 287: 1627CrossRefGoogle Scholar
  26. 26.
    Finkelstein, JA, Jamieson, CG (1987) An association between anti-inflammatory medication and internal pelvic fistulas. Dis Col Rect 30: 168–170CrossRefGoogle Scholar
  27. 27.
    Freeman, HJ (1986) Sulindac-associated small bowel lesion. J Clin Gastroenterol 8: 569–571PubMedCrossRefGoogle Scholar
  28. 28.
    Gizzi, G, Villani, V, Brandi, G, Paganelli, GM, Di Febo, G (1990) Ano-rectal lesions in patients taking suppositories containing non-steroidal antiinflammatory drugs. Endoscopy 22: 146–248PubMedCrossRefGoogle Scholar
  29. 29.
    Glanborg-Jorgensen, T, Weis-Fough, US, Neilsen, HH, Olsen, HP (1976) Salicylate and aspirin-induced uncoupling of oxidative phosphorylation in mitochondria isolated from the mucosal membrane of the stomach. Scand J Clin Invest 36: 649–653CrossRefGoogle Scholar
  30. 30.
    Graham, DY, Agrawal, NM, Roth, S (1988) Prevention of non-steroidal antiinflammatory drug induced gastric ulceration with Misoprostol; multicenter, double blind placebo controlled trial. Lancet II: 1277–1280CrossRefGoogle Scholar
  31. 31.
    Graham, DY (1990) The relationship between NSAID use and peptic ulcer disease. Gastroenterol Clin N Am 19: 171–182Google Scholar
  32. 32.
    Granger, DN, Benoit, JN, Suzuki, M, Grisham, MB (1985) Leucocyte adherence to venular endothelium during ischemia perfusion. Am J Physiol 257: G683–G688Google Scholar
  33. 33.
    Griffin, MR, Ray, WA, Schaffner, W (1988) NSAID use and death from peptic ulcer in the elderly. Ann Intern Med 109: 359–364PubMedGoogle Scholar
  34. 34.
    Griffin, MR, Piper, JM, Dougherty, JR, Snowden, M, Ray, WA (1991) Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 114: 257–263PubMedGoogle Scholar
  35. 35.
    Hall, RI, Petty, AH, Cobden, I, Lendrum, R (1983) Enteritis and colitis associated with mefenamic acid. Br Med J 287: 1182CrossRefGoogle Scholar
  36. 36.
    Hansen, TM, Hansen, NE, Birgens, HS, Holund, B, Lorenzen, I (1983) Serum ferritin and the assessment of iron deficiency in rheumatoid arthritis. Scand J Gastroenterol 12: 353–359Google Scholar
  37. 37.
    Hayllar, J, Somasundaram, S, Sarathchandra, P, Levi AJ, Bjarnason, I (1990) Early cellular events in the pathogenesis of NSAID enteropathy in the rat. Gastroenterology 100: A216Google Scholar
  38. 38.
    Hayllar, J, MacPherson, A, Bjarnason, I (1992) Gastroprotection and nonsteroidal anti-inflammatory drugs Drug Safety 7: 86–105Google Scholar
  39. 39.
    Hershfîeld, NB (1992) Endoscopic description of diaphragm disease induced by nonsteroidal anti-inflammatory drugs. Gastroint Endosc 38: 267Google Scholar
  40. 40.
    Huber, T, Ruchti, C, Halter, F (1991) Nonsteroidal antiinflammatory drug-induced colonic strictures: a case report. Gastroenterology 100: 1119–1122PubMedGoogle Scholar
  41. 41.
    Isaacs PET, Sladen, GE, Filpie, I (1987) Mefenamic acid enteropathy. J Clin Pathol 40: 121–127CrossRefGoogle Scholar
  42. 42.
    Johnson, F (1987) Recurrent small bowel obstruction with piroxicam. Br J Surg 74: 654CrossRefGoogle Scholar
  43. 43.
    Kaedekar, DK (1973) Effects of salicylate and related compounds in gastric HCl secretions. Am J Physiol 225: 521–527Google Scholar
  44. 44.
    Kaufman, HJ, Taubin, HL (1987) NSAID activate quiescent inflammatory bowel disease. Ann Intern Med 107: 513–516Google Scholar
  45. 45.
    Kent, TH, Cardeli RM, Stanler, FU (1969) Small intestinal ulcers and intestinal flora in rats given indomethacin. Am J Pathol 54: 237–245PubMedGoogle Scholar
  46. 46.
    Lang, J, Price AB, Levi AJ, Burk, M, Gumpel, JM, Bjarnason, I (1988) Diaphragm disease: the pathology of non-steroidal anti-inflammatory drug induced small intestinal strictures. J Clin Path 41: 516–526PubMedCrossRefGoogle Scholar
  47. 47.
    Langman, MJS (1989) Epidemiological evidence on the association between peptic ulceration and antiinflammatory drugs. Gastroenterology 96: 640–646PubMedGoogle Scholar
  48. 48.
    Levy, N, Gaspar, E (1975) Rectal bleeding and indomethacin suppositories. Lancet I: 577CrossRefGoogle Scholar
  49. 49.
    Malech, MI, Callin, JI (1987) Neutrophils in human disease. N Eng J Med 317: 687–694CrossRefGoogle Scholar
  50. 50.
    Morris, AJ, Madhock, R, Sturrock, RD, Capell, HA, MacKenzie, JF (1991) Enteroscopic diagnosis of small bowel ulceration in patients receiving nonsteroidal anti-inflammatory drugs. Lancet 337: 520PubMedCrossRefGoogle Scholar
  51. 51.
    Morris, AJ, Wasson, LA, MacKenzie, JF (1992) Small bowel enteroscopy in undiagnosed gastrointestinal blood loss. Gut 33: 887–889PubMedCrossRefGoogle Scholar
  52. 52.
    Nagaraj, HS, Sandhu, AS, Cook, LN, Buchuno, JT, Groff, DB (1981) Gastrointestinal perforation following indomethacin in very low birth weight infants. J Paedriat Surg 16: 1003–1007CrossRefGoogle Scholar
  53. 53.
    Pearson, DJ, Stones, NA, Bentley, SJ, Reid, H (1983) Proctocolitis induced by salicylate and associated with asthma and recurrent nasal polyps. Br Med J 287: 1675CrossRefGoogle Scholar
  54. 54.
    Phillips, MS, Fehilly, B, Stewart, S, Dronfield, WM (1983) Enteritis and colitis associated with mefenamic acid. Br Med J 287: 1626–1627Google Scholar
  55. 55.
    Rampton, DS, Sladen, GGE (1981) Relapse of ulcerative proctocolitis during treatment with NSAID. Postgrad Med J 57: 297–299PubMedCrossRefGoogle Scholar
  56. 56.
    Rampton, DS, Trapping, PJ (1983) Enteritis and colitis associated with mefenamic acid. Br Med J 287: 1627CrossRefGoogle Scholar
  57. 57.
    Rampton, DS, McNeil, NI, Sarner, M (1983) Analgesic ingestion and other factors preceding relapse in ulcerative colitis. Gut 24: 187–189PubMedCrossRefGoogle Scholar
  58. 58.
    Ravi, S, Keat, AC, Keat, ECB (1986) Colitis caused by NSAID. Postgrad Med J 62: 773–776PubMedCrossRefGoogle Scholar
  59. 59.
    Robert, A (1975) Cytoprotection by prostaglandins. Gastroenterlogy 77: 761–767Google Scholar
  60. 60.
    Robert, A, Asano, T (1977) Resistance of germ free rats to indomethacin-induced intestinal lesions. Prostaglandins 14: 331–341CrossRefGoogle Scholar
  61. 61.
    Rooney, PJ, Jenkins, RT, Smith, KM, Coates, G (1986) 111-Indium-labelled polymorphonuclear leucocyte scans in rheumatoid arthritis — an important clinical cause of positive results. Br J Rheumatol 25: 167–170PubMedCrossRefGoogle Scholar
  62. 62.
    Rutherford, D, Stockdill, G, Hammer-Hodges, DW, Ferguson, A (1984) Proctocolitis induced by salicylates. Br Med J 288: 794CrossRefGoogle Scholar
  63. 63.
    Satoh, H, Guth, PH, Grossmann, MI (1983) Role of bacteria in gastric ulceration produced by indomethacin in the rat: cytoprotective action of antibiotics. Gastroenterology 84: 483–489PubMedGoogle Scholar
  64. 64.
    Saverymuttu, SH, Peters, AM, Lavender, JP, Hodgson, HJ, Chadwick, VS (1983) 111-Indium autologous leucocytes in inflammatory bowel disease. Gut 24: 293–299PubMedCrossRefGoogle Scholar
  65. 65.
    Saverymuttu, SH, Peters, AM, Lavender, JP, Hodgson, H, Chadwick, VS (1983) Quantitative faecal indium-111 labelled leucocyte excretion assessment of disease activity in Chron’s disease. Gastroenterology 85: 1333–1339PubMedGoogle Scholar
  66. 66.
    Saverymuttu, SH, Camilleri, M, Rees, H, Cavender, TP, Hodgson, HJF (1986) Indium-111 granulocyte scanning comparison with colonoscopy, histology and faecal indium-Ill excretion in assessing disease extent and activity in colitis. Gastroenterology 90: 1121–1128PubMedGoogle Scholar
  67. 67.
    Segal, AW, Isenberg, DA, Hajirousow, V, Tolfree, S, Clark, J, Smaith, ML (1986) Preliminary evidence for gut involvement in the pathogenesis of rheumatoid arthritis? Br J Rheumatol 25: 162–166PubMedCrossRefGoogle Scholar
  68. 68.
    Segall, AW (1990) The electron transport chain of the microbicidal oxidase of phagocytic cells and its involvement in the molecular pathology of chronic granulomatous disease. In: Peters, TJ (ed) The cell biology of inflammation in the gastrointestinal tract. Corners Publication, Hull, pp 51–73Google Scholar
  69. 69.
    Somasundaram, S, Macpherson, AJ, Hayllar, J, Saratchandra, P, Bjarnason, I (1992) Enterocyte mitochondrial damage due to NSAID in the rat. Gut 33 (Suppl.): S5CrossRefGoogle Scholar
  70. 70.
    Somasundaram, S, Hayllar, J, Macpherson, A, Bjarnason, I (1993) The biochemical basis of NSAID-induced gastrointestinal damage: a review and a hypothesis. To be publishedGoogle Scholar
  71. 71.
    Sommerville, K, Faulkner, G, Langman, M (1986) Non-steroidal antiinflammatory drugs and bleeding peptic ulcer. Lancet 1: 462–464CrossRefGoogle Scholar
  72. 72.
    Spenny, JG, Bhown, M (1977) Effects of acetylsalicylic acid on gastric mucosa. II. Mucosal ATP and phosphocreatine content and salicylic effects on mitochondrial metabolism. Gastroenterlogy 73: 995–999Google Scholar
  73. 73.
    Stewart, JT, Pennington, CR, Pringle, R (1985) Anti-inflammatory drugs and bowel perforation und haemorrhage. Br Med J 290: 787–788CrossRefGoogle Scholar
  74. 74.
    Sukumar, L (1987) Recurrent small bowel obstruction with piroxicam. Br J Surg 74: 186PubMedCrossRefGoogle Scholar
  75. 75.
    Tancer, ML, Zahiruddin, S (1966) Diagnosis of sigmoidovaginal fistula by vaginogram. Obst Gynecol 28: 815–819Google Scholar
  76. 76.
    Tanner, AR, Raghunat, H (1988) Colonic inflammation and NSAID administration. Digestion 41: 116–120PubMedCrossRefGoogle Scholar
  77. 77.
    Teahon, K, Webster, D, Price, AB, Levi, AJ, Bjarnason, I (1991) Hypogamma-globulinaemic enteropathy. Gastroenterology 100: A620Google Scholar
  78. 78.
    Vreudgenhil, G, Wognum, AW, Van Hijk, HG, Swaak, AJG (1990) Anaemia in rheumatoid arthritis: the role of iron, vitamin B 12, for folic acid and erythropoietin responsiveness. Ann Rheum Dis 49: 93–98CrossRefGoogle Scholar
  79. 79.
    Wallace, JL, Keenan, CM, Granger, DN (1990) Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil dependent process. Am J Physiol 259: G462–G467PubMedGoogle Scholar
  80. 80.
    Wallace, JL, Arfors, KE, McKnight, GW (1991) A monoclonal antibody against the CD 18 leucocyte adhesion molecule prevents indomethacin-induced gastric damage in the rabbit. Gastroenterology 100: 878–883PubMedGoogle Scholar
  81. 81.
    Walls, J, Bell, D, Schora, W (1968) Rectal bleeding and indomethacin. Br Med J I:52CrossRefGoogle Scholar
  82. 82.
    Weiss, SJ (1989) Tissue destruction by neutrophils N. Engl J Med 320: 365–376PubMedCrossRefGoogle Scholar
  83. 83.
    Wilkinson, PC (1990) Leucocyte locomotion: determinants of locomotor capacity, Chemotaxis and chemokinesis. In: Peters, TJ (ed) The cell biology of inflammation in the gastrointestinal tract. Corners Publication, Hull, pp 15–27Google Scholar
  84. 84.
    Wilson, RG, Smith, AN, Maclntyre, IMC (1990) Complications of diverticular disease and nonsteroidal anti-inflammatory drugs: a prospective study. Br J Surg 77: 1103–1104PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • A. Macpherson
    • 1
  • I. Bjarnason
    • 1
  1. 1.King’s College School of Medicine and DentistryDepartments of Clinical Biochemistry and MedicineLondonUK

Personalised recommendations